These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ethical considerations on pharmacogenomics. Mordini E Pharmacol Res; 2004 Apr; 49(4):375-9. PubMed ID: 15202517 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. Corrigan OP J Med Ethics; 2005 Mar; 31(3):144-8. PubMed ID: 15738433 [TBL] [Abstract][Full Text] [Related]
4. Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Smart A; Martin P; Parker M Bioethics; 2004 Aug; 18(4):322-42. PubMed ID: 15449405 [TBL] [Abstract][Full Text] [Related]
6. Tailor-made pharmacotherapy: future developments and ethical challenges in the field of pharmacogenomics. van Delden J; Bolt I; Kalis A; Derijks J; Leufkens H Bioethics; 2004 Aug; 18(4):303-21. PubMed ID: 15449404 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics--legal, ethical and regulatory considerations. March R; Cheeseman K; Doherty M Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282 [TBL] [Abstract][Full Text] [Related]
8. Lack of data privacy could hamper pharmacogenomics studies. Howard K Nat Rev Drug Discov; 2004 Sep; 3(9):725. PubMed ID: 15368651 [No Abstract] [Full Text] [Related]
9. The potential and limitations of personalized medicine in the doctor-patient relationship. Hapgood R Pharmacogenomics; 2003 Nov; 4(6):685-7. PubMed ID: 14596632 [No Abstract] [Full Text] [Related]
10. Rhetoric and hype: where's the 'ethics' in pharmacogenomics? Williams-Jones B; Corrigan OP Am J Pharmacogenomics; 2003; 3(6):375-83. PubMed ID: 14672518 [TBL] [Abstract][Full Text] [Related]
12. Erice declaration of the ethical principles of pharmacogenetic research. Temporary Committee on Human Genetics and Other New Technologies of Modern Medicine. Temporary Committee on Human Genetics and Other New Technologies of Modern Medicine Rev Derecho Genoma Hum; 2002; (17):223-8. PubMed ID: 12703117 [No Abstract] [Full Text] [Related]
13. The ethics of pharmacogenomics. Neil D; Craigie J Monash Bioeth Rev; 2004 Apr; 23(2):9-20. PubMed ID: 15810202 [TBL] [Abstract][Full Text] [Related]
14. Nuffield Council on Bioethics consultation. Lipton P Pharmacogenomics; 2003 Jan; 4(1):91-5. PubMed ID: 12517289 [TBL] [Abstract][Full Text] [Related]
15. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations. Morley KI; Hall WD J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045 [TBL] [Abstract][Full Text] [Related]
16. Emerging ethical issues in pharmacogenomics: from research to clinical practice. Freund CL; Wilfond BS Am J Pharmacogenomics; 2002; 2(4):273-81. PubMed ID: 12421098 [TBL] [Abstract][Full Text] [Related]
17. Racializing drug design: implications of pharmacogenomics for health disparities. Lee SS Am J Public Health; 2005 Dec; 95(12):2133-8. PubMed ID: 16257939 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics and children: meeting the ethical challenges. Freund CL; Clayton EW Am J Pharmacogenomics; 2003; 3(6):399-404. PubMed ID: 14672521 [TBL] [Abstract][Full Text] [Related]
19. Reprogenetics and pharmacogenetics: in whose best interests? Mackenzie R Med Law; 2005 Jun; 24(2):343-54. PubMed ID: 16082870 [TBL] [Abstract][Full Text] [Related]